{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03520569","recordId":"NCT03520569","peptideSlug":"octreotide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03520569-octreotide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct03520569.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct03520569.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2018-05-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"octreotide","submittedDate":"2018-05-08","publishedAt":"2026-08-23","recordId":"NCT03520569","recordSha256":"eeed373d08e4ae3d14d4e0a319a8cc854c6388e44cc80a3278e1e2c12f59ad61","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03520569?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Identification","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2019-12-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"octreotide","submittedDate":"2019-12-17","publishedAt":"2026-08-23","recordId":"NCT03520569","recordSha256":"ac001dae46eebb7d82e7437d27fb45c2532a75042e6f9cd515838acfb4c22306","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03520569?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2020-02-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"octreotide","submittedDate":"2020-02-05","publishedAt":"2026-08-23","recordId":"NCT03520569","recordSha256":"d79585fbff477bc0ed50d9420fb0707f5eed4108926920378de2f6415d3fc117","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03520569?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","Contacts/Locations","Document Section","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Design","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2022-04-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"octreotide","submittedDate":"2022-04-20","publishedAt":"2026-08-23","recordId":"NCT03520569","recordSha256":"55dd561bd8edab56bf006401674d28319ace465f83c64488ebea2d522108ba1b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03520569?a=5&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"98d58d8b370304c1329f94c048cb91bc156d627a46b36797bf04f1d17da83e56"}}